Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Illumina Inc. (NASDAQ:ILMN)

This company has been moved to the archive! The financial data has not been updated since November 5, 2021.

Total Asset Turnover
since 2005

Microsoft Excel

Calculation

Illumina Inc., total asset turnover, long-term trends, calculation

Microsoft Excel
Total asset turnover = Revenue1 ÷ Total assets1
Dec 31, 2020 0.43 = 3,239 ÷ 7,585
Dec 29, 2019 0.48 = 3,543 ÷ 7,316
Dec 30, 2018 0.48 = 3,333 ÷ 6,959
Dec 31, 2017 0.52 = 2,752 ÷ 5,257
Jan 1, 2017 0.56 = 2,398 ÷ 4,281
Jan 3, 2016 0.60 = 2,220 ÷ 3,688
Dec 28, 2014 0.56 = 1,861 ÷ 3,340
Dec 29, 2013 0.47 = 1,421 ÷ 3,019
Dec 30, 2012 0.45 = 1,149 ÷ 2,566
Jan 1, 2012 0.48 = 1,056 ÷ 2,196
Jan 2, 2011 0.49 = 903 ÷ 1,839
Jan 3, 2010 0.47 = 666 ÷ 1,430
Dec 28, 2008 0.42 = 573 ÷ 1,377
Dec 30, 2007 0.37 = 367 ÷ 988
Dec 31, 2006 0.61 = 185 ÷ 301
Jan 1, 2006 0.73 = 74 ÷ 101

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

1 US$ in millions

The financial trajectory from 2006 to 2020 is characterized by aggressive expansion in both top-line revenue and the total asset base. Revenue grew from 74 million US dollars in 2006 to a peak of 3.54 billion US dollars in 2019, before experiencing a slight contraction to 3.24 billion US dollars in 2020. Concurrently, total assets expanded significantly from 101 million US dollars to 7.59 billion US dollars over the same period, indicating a substantial increase in the company's scale and investment capacity.

Total Asset Turnover Trends
The total asset turnover ratio exhibits three distinct phases of volatility. An initial sharp decline occurred between 2006 and 2007, where the ratio dropped from 0.73 to a period low of 0.37. This was followed by a sustained recovery phase from 2008 through 2016, with the ratio climbing steadily to reach a peak of 0.60. However, a downward trend emerged after 2016, with the ratio receding to 0.43 by 2020.
Asset Efficiency and Scaling
The fluctuation in the asset turnover ratio suggests varying levels of efficiency in utilizing assets to generate sales. The steep decline in 2007 indicates that asset growth significantly outpaced revenue growth during that window. The subsequent recovery through 2016 suggests a period of improved operational leverage where revenue growth caught up to the expanded asset base. The most recent decline through 2020 implies that the accumulation of assets has once again exceeded the rate of revenue generation, leading to reduced asset productivity.
Revenue and Asset Correlation
While revenue demonstrated consistent growth for nearly the entire period, the total asset base grew at a more aggressive pace. The expansion of assets from approximately 3.69 billion US dollars in 2016 to 7.59 billion US dollars in 2020 coincided with a flattening of revenue growth, which explains the compression of the asset turnover ratio in the final four years of the analysis.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Comparison to Competitors

Illumina Inc., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel
Illumina Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Inc.
Dec 31, 2020 0.43 0.30 0.39 0.36 0.29 0.53 0.36 0.47 0.52 0.28 0.50 0.47 0.53
Dec 29, 2019 0.48 0.37 0.37 0.20 0.29 0.57 0.36 0.52 0.55 0.31 0.53 0.44 0.50
Dec 30, 2018 0.48 0.55 0.34 0.64 0.42 0.56 0.34 0.53 0.51 0.34 0.57 0.43 0.49
Dec 31, 2017 0.52 0.40 0.27 0.62 0.39 0.51 0.37 0.49 0.46 0.31 0.67 0.37 0.70
Jan 1, 2017 0.56 0.39 0.28 0.58 0.37 0.55 0.53 0.51 0.42 0.31 0.70 0.40 0.59
Jan 3, 2016 0.60 0.43 0.29 0.52 0.43 0.56 0.62 0.53 0.39 0.29 0.73 0.41 0.41
Dec 28, 2014 0.56 0.72 0.28 0.47 0.54 0.53 0.71 0.57 0.43 0.29 0.73 0.39 0.25
Dec 29, 2013 0.47 0.64 0.28 0.42 0.55 0.66 0.48 0.54 0.42 0.30 0.71 0.41 0.52
Dec 30, 2012 0.45 0.68 0.31 0.49 0.55 0.66 0.44 0.55 0.45 0.32 0.66 0.46 0.55
Jan 1, 2012 0.48 — 0.31 0.64 0.54 0.72 0.47 0.57 0.46 0.36 0.34 0.44 0.64
Jan 2, 2011 0.49 — 0.34 0.63 0.59 0.74 0.64 0.60 0.43 0.35 0.42 0.51 0.08
Jan 3, 2010 0.47 — 0.36 0.61 0.57 0.80 0.67 0.65 0.24 0.23 0.51 0.47 0.05
Dec 28, 2008 0.42 — 0.40 0.70 0.73 0.70 0.72 0.75 0.51 0.43 0.36 0.50 0.18
Dec 30, 2007 0.37 — 0.41 0.74 0.63 0.70 0.64 0.75 0.50 0.42 0.13 0.46 0.33
Dec 31, 2006 0.61 — 0.41 0.70 0.75 0.71 0.63 0.76 0.51 0.42 0.11 0.18 0.23
Jan 1, 2006 0.73 — 0.41 0.68 0.87 0.60 0.48 0.87 0.49 0.44 0.16 0.62 0.29

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Illumina Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Illumina Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2020 0.43 0.39
Dec 29, 2019 0.48 0.39
Dec 30, 2018 0.48 0.45
Dec 31, 2017 0.52 0.40
Jan 1, 2017 0.56 0.41
Jan 3, 2016 0.60 0.42
Dec 28, 2014 0.56 0.44
Dec 29, 2013 0.47 0.43
Dec 30, 2012 0.45 0.45
Jan 1, 2012 0.48 0.47
Jan 2, 2011 0.49 0.47
Jan 3, 2010 0.47 0.39
Dec 28, 2008 0.42 0.57
Dec 30, 2007 0.37 0.56
Dec 31, 2006 0.61 0.54
Jan 1, 2006 0.73 0.57

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

Comparison to Industry (Health Care)

Illumina Inc., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel
Illumina Inc. Health Care
Dec 31, 2020 0.43 0.57
Dec 29, 2019 0.48 0.57
Dec 30, 2018 0.48 0.63
Dec 31, 2017 0.52 0.56
Jan 1, 2017 0.56 0.57
Jan 3, 2016 0.60 0.55
Dec 28, 2014 0.56 0.60
Dec 29, 2013 0.47 0.58
Dec 30, 2012 0.45 0.58
Jan 1, 2012 0.48 0.61
Jan 2, 2011 0.49 0.61
Jan 3, 2010 0.47 0.55
Dec 28, 2008 0.42 0.73
Dec 30, 2007 0.37 0.71
Dec 31, 2006 0.61 0.69
Jan 1, 2006 0.73 0.66

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).